Adeline Vulin

1.7k total citations
15 papers, 1.0k citations indexed

About

Adeline Vulin is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Adeline Vulin has authored 15 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Genetics and 3 papers in Genetics. Recurrent topics in Adeline Vulin's work include Muscle Physiology and Disorders (10 papers), Virus-based gene therapy research (4 papers) and RNA Interference and Gene Delivery (4 papers). Adeline Vulin is often cited by papers focused on Muscle Physiology and Disorders (10 papers), Virus-based gene therapy research (4 papers) and RNA Interference and Gene Delivery (4 papers). Adeline Vulin collaborates with scholars based in France, United States and United Kingdom. Adeline Vulin's co-authors include Luis Garcı́a, Aurélie Goyenvalle, Jean‐Claude Kaplan, France Leturcq, Françoise Fougerousse, Olivier Danos, Magali Hay, Armelle Prunier, Michèle T. Martin and J.H. Hendry and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Adeline Vulin

15 papers receiving 992 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adeline Vulin France	11	780	287	165	147	116	15	1.0k
Cecilia Dyer United States	10	605 0.8×	527 1.8×	27 0.2×	156 1.1×	24 0.2×	16	941
Tamara Goode United States	14	797 1.0×	742 2.6×	19 0.1×	192 1.3×	36 0.3×	23	1.2k
Kim E. Wells United Kingdom	15	724 0.9×	276 1.0×	41 0.2×	70 0.5×	10 0.1×	25	896
Juliette Hordeaux United States	13	496 0.6×	514 1.8×	17 0.1×	106 0.7×	30 0.3×	23	842
Benoît Brouwers Belgium	6	1.3k 1.7×	876 3.1×	18 0.1×	134 0.9×	225 1.9×	7	1.9k
Peter P. Nghiem United States	16	475 0.6×	116 0.4×	104 0.6×	54 0.4×	6 0.1×	28	784
Daniele dos Santos Martins Brazil	16	344 0.4×	121 0.4×	62 0.4×	336 2.3×	19 0.2×	83	1.0k
Aime K. Johnson United States	14	393 0.5×	295 1.0×	38 0.2×	63 0.4×	14 0.1×	47	696
Ling T. Guo United States	19	880 1.1×	213 0.7×	15 0.1×	109 0.7×	11 0.1×	74	1.2k
Dominique Poncelet Belgium	9	1.9k 2.5×	939 3.3×	15 0.1×	136 0.9×	218 1.9×	15	2.4k

Countries citing papers authored by Adeline Vulin

Since Specialization

Citations

This map shows the geographic impact of Adeline Vulin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adeline Vulin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adeline Vulin more than expected).

Fields of papers citing papers by Adeline Vulin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adeline Vulin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adeline Vulin. The network helps show where Adeline Vulin may publish in the future.

Co-authorship network of co-authors of Adeline Vulin

This figure shows the co-authorship network connecting the top 25 collaborators of Adeline Vulin. A scholar is included among the top collaborators of Adeline Vulin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adeline Vulin. Adeline Vulin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Wein, Nicolas, Adeline Vulin, Liubov V. Gushchina, et al.. (2022). Systemic delivery of an AAV9 exon-skipping vector significantly improves or prevents features of Duchenne muscular dystrophy in the Dup2 mouse. Molecular Therapy — Methods & Clinical Development. 26. 279–293. 20 indexed citations

Vulin, Adeline, et al.. (2020). Current Status of Antisense Oligonucleotide-Based Therapy in Neuromuscular Disorders. Drugs. 80(14). 1397–1415. 9 indexed citations

Barthélémy, Inès, Nadège Calmels, Robert B. Weiss, et al.. (2020). X-linked muscular dystrophy in a Labrador Retriever strain: phenotypic and molecular characterisation. Skeletal Muscle. 10(1). 23–23. 13 indexed citations

Vulin, Adeline, Nicolas Sévenet, Pascal Soularue, et al.. (2018). Severe PATCHED1 Deficiency in Cancer-Prone Gorlin Patient Cells Results in Intrinsic Radiosensitivity. International Journal of Radiation Oncology*Biology*Physics. 102(2). 417–425. 10 indexed citations

Wein, Nicolas, Adeline Vulin, Andrew R. Findlay, et al.. (2017). Efficient Skipping of Single Exon Duplications in DMD Patient-Derived Cell Lines Using an Antisense Oligonucleotide Approach. Journal of Neuromuscular Diseases. 4(3). 199–207. 25 indexed citations

Martin, Michèle T., Adeline Vulin, & J.H. Hendry. (2016). Human epidermal stem cells: Role in adverse skin reactions and carcinogenesis from radiation. Mutation Research/Reviews in Mutation Research. 770(Pt B). 349–368. 44 indexed citations

Vulin, Adeline, et al.. (2015). The first exon duplication mouse model of Duchenne muscular dystrophy: A tool for therapeutic development. Neuromuscular Disorders. 25(11). 827–834. 27 indexed citations

Vulin, Adeline, Nicolas Wein, Eric K. Johnson, et al.. (2013). The ZZ Domain of Dystrophin in DMD: Making Sense of Missense Mutations. Human Mutation. 35(2). 257–264. 21 indexed citations

Vulin, Adeline, Inès Barthélémy, Aurélie Goyenvalle, et al.. (2012). Muscle Function Recovery in Golden Retriever Muscular Dystrophy After AAV1-U7 Exon Skipping. Molecular Therapy. 20(11). 2120–2133. 106 indexed citations

10.

Chaouch, Soraya, Vincent Mouly, Aurélie Goyenvalle, et al.. (2009). Immortalized Skin Fibroblasts Expressing Conditional MyoD as a Renewable and Reliable Source of Converted Human Muscle Cells to Assess Therapeutic Strategies for Muscular Dystrophies: Validation of an Exon-Skipping Approach to Restore Dystrophin in Duchenne Muscular Dystrophy Cells. Human Gene Therapy. 20(7). 784–790. 54 indexed citations

11.

Amthor, Helge, Anthony Otto, Adeline Vulin, et al.. (2009). Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity. Proceedings of the National Academy of Sciences. 106(18). 7479–7484. 149 indexed citations

12.

Vulin, Adeline, Aurélie Goyenvalle, Inès Barthélémy, et al.. (2006). 918. Rescue of Dystrophin in the GRMD Dog by Multi-Exon Skipping Using Engineered U7 snRNAs. Molecular Therapy. 13. S354–S354. 1 indexed citations

13.

Goyenvalle, Aurélie, Adeline Vulin, Françoise Fougerousse, et al.. (2004). Rescue of Dystrophic Muscle Through U7 snRNA-Mediated Exon Skipping. Science. 306(5702). 1796–1799. 370 indexed citations

14.

Goyenvalle, Aurélie, Adeline Vulin, Françoise Fougerousse, et al.. (2004). Le saut d’exon thérapeutique : un espoir pour les dystrophinopathies. médecine/sciences. 20(12). 1163–1165. 3 indexed citations

15.

Hay, Magali, et al.. (2003). Assessment of pain induced by castration in piglets: behavioral and physiological responses over the subsequent 5 days. Applied Animal Behaviour Science. 82(3). 201–218. 175 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact